ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Zytiga 500 mg, Filmtabletten - 56
66431001 Janssen-Cilag AG
Zytiga 500 mg, Filmtabletten14.09.2017
Original14.09.2017
Abiraterone (L02BX03) 
WHO-DDD 
07.16.20.56
07.16.20. 
B  
Yes 
IPCI
2276.07Yes
    
20 %2406.15
7680664310016Synthetika
7273563 
Composition
abirateroni acetas 500 mg corresp. abirateronum 446 mg, lactosum monohydricum corresp. lactosum 240.5 mg, carmellosum natricum conexum et natrii laurilsulfas corresp. natrium 10.42 mg, hypromellosum, cellulosum microcristallinum silicificatum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (rubrum), E 172 (nigrum), pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Abirateroni Acetas500 mg correspond Abirateronum 446 mg
BAG: Active AgentDose
Abirateroni Acetas500 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
(Rubrum)  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum Silicificatum  
E 171 color.
E 172 color.
Hypromellosum  
Lactose Monohydrate  
Macrogol3350  
Magnesii Stearas  
Natrii Laurilsulfas  
Poly(Alcohol Vinylicus) Überzug
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 05.05.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home